Fusobacterium nucleatum helps CRC cells resist chemotherapy through the TLR4-Myd88 pathway, while butyrate secreted by Faecalibacterium prausnitzii inhibits CRC cell growth. Here, MYD88 is linked to colorectal carcinoma.